Success Metrics

Clinical Success Rate
88.2%

Based on 45 completed trials

Completion Rate
88%(45/51)
Active Trials
40(35%)
Results Posted
51%(23 trials)
Terminated
6(5%)

Phase Distribution

Ph phase_1
4
3%
Ph phase_2
18
16%
Ph early_phase_1
1
1%
Ph not_applicable
77
67%
Ph phase_4
2
2%
Ph phase_3
13
11%

Phase Distribution

5

Early Stage

18

Mid Stage

15

Late Stage

Phase Distribution115 total trials
Early Phase 1First-in-human
1(0.9%)
Phase 1Safety & dosage
4(3.5%)
Phase 2Efficacy & side effects
18(15.7%)
Phase 3Large-scale testing
13(11.3%)
Phase 4Post-market surveillance
2(1.7%)
N/ANon-phased studies
77(67.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.9%

45 of 53 finished

Non-Completion Rate

15.1%

8 ended early

Currently Active

40

trials recruiting

Total Trials

115

all time

Status Distribution
Active(56)
Completed(45)
Terminated(8)
Other(6)

Detailed Status

Completed45
Recruiting32
Not yet recruiting14
Active, not recruiting8
Terminated6
unknown6

Development Timeline

Analytics

Development Status

Total Trials
115
Active
40
Success Rate
88.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.9%)
Phase 14 (3.5%)
Phase 218 (15.7%)
Phase 313 (11.3%)
Phase 42 (1.7%)
N/A77 (67.0%)

Trials by Status

enrolling_by_invitation22%
completed4539%
withdrawn22%
terminated65%
active_not_recruiting87%
recruiting3228%
unknown65%
not_yet_recruiting1412%

Recent Activity

Clinical Trials (115)

Showing 20 of 115 trialsScroll for more
NCT06311162Not Applicable

Early Life Intervention in Pediatrics Supported by E-health - SMOKE

Recruiting
NCT04197765Not Applicable

acTBS Treatment for Inpatient Subjects With Suicidality

Active Not Recruiting
NCT04502563Not Applicable

LINK-HF2 - Remote Monitoring Analytics in Heart Failure

Completed
NCT07215234Phase 1

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Recruiting
NCT07246473Not Applicable

Non-invasive Ultrasound and Hematoma Clearance After Intracerebral Hemorrhage

Recruiting
NCT05887713Not Applicable

Novel Mental Health Therapies to Improve Military Readiness

Active Not Recruiting
NCT06872125Phase 3

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Recruiting
NCT05992831Not Applicable

Transcranial Magnetic Stimulation for MCI

Recruiting
NCT05135091Phase 3

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

Recruiting
NCT06949969Not Applicable

Alesis OSA-1 Obstructive Sleep Apnea Treatment

Completed
NCT02032004Phase 3

Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure

Completed
NCT05099770Phase 3

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Recruiting
NCT06353529Phase 4

Postop Pain Management in Pituitary Tumour Patients

Recruiting
NCT07462533Phase 2

Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

Not Yet Recruiting
NCT07292623Not Applicable

Effects of Transcutaneous Vagus Nerve Stimulation in Older Adults

Completed
NCT07401147Not Applicable

Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management During Labor.

Recruiting
NCT06955923Phase 2

Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty

Completed
NCT06688578Not Applicable

Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait

Recruiting
NCT03632044Phase 4

Evaluation of Trigeminal Nerve Blockade

Active Not Recruiting
NCT07052721Not Applicable

Randomized Study of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Shoulder/Foot Surgery

Enrolling By Invitation

Drug Details

Intervention Type
OTHER
Total Trials
115